Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

NCT: NCT07220330 · ENROLLING_BY_INVITATION

NCT IDNCT07220330
StatusENROLLING_BY_INVITATION
Start Date2025-01-15

Brief Summary

The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑